Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tizanidine ER driving simulator crossover study
NL-OMON42658Phase 2Active, not recruiting
- Sponsor
- Sun Pharma Advanced Research Company
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tizanidine in acute musculoskeletal pain (4 arms), sponsored by Sun Pharma Advanced Research Company. Primary endpoint: Standard deviation of lateral position. Started Apr 2016; status: active, not recruiting.
02
Drugs
tizanidine
03
Conditions
acute musculoskeletal pain
Beyond the preview
Go deeper on NL-OMON42658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42658.